Back to the article

HealthRX.com · Printable appeal checklist

Zepbound Medicaid request and fair hearing packet

Record whether your state covers Zepbound for weight management at all, collect what a prior authorization usually needs, and track every decision against the federal managed-care and fair hearing deadlines. Two state examples show how far the answer can differ.

Companion to “Does State Medicaid Cover Zepbound? A State-by-State Guide to Coverage, Prior Authorization, and Appeals” · healthrx.com/zepbound/medicaid-coverage · Facts checked 2026-10-18

Your Medicaid coverage

State and program
Fee-for-service or managed-care planplan name if managed care
Does the state list Zepbound for weight management?document title and date checked
Diagnosis on the requestobesity, sleep apnea or another use

Prior authorization file

  • BMI with the date it was measured, and earlier BMI readings
  • Weight-related conditions with records: sleep study, A1c trend, blood pressure log, lipid panel
  • Diet and exercise program: dates and what it included
  • Earlier weight-loss medicines: names, doses, dates and why each stopped
  • Any contraindication to a required first-step medicine
  • Specialist note, if the state asks for one

Federal rules (U.S. Code and 42 CFR)

  • States may exclude or restrict drugs used for weight loss from Medicaid coverage.[1]
  • A state prior authorization program must respond within 24 hours of a request.[1]
  • Managed-care members have 60 calendar days from the denial notice to request a plan appeal.[2]
  • The plan resolves a standard appeal within 30 calendar days, or an expedited one within 72 hours.[3]
  • After the plan's decision, the state must allow 90 to 120 days to request a State fair hearing.[3]
  • The state ordinarily decides the fair hearing within 90 days.[4]

How two states answer

  • Missouri lists Zepbound for obesity at BMI 30 or more, or 27 or more with a weight-related condition, for ages 18 and up.[5]
  • California removed Zepbound from its Contract Drugs List on January 1, 2026 and considers requests only for sleep apnea.[6]

Decisions, appeals and hearing dates

DateDecision or filingReference numberDeadline it setsDone

Questions for the plan or state

  1. Is the denial a benefit exclusion or a missing-criteria decision?
  2. Which criteria document did the reviewer use, and what does it require?
  3. Can I ask for an expedited appeal, and who decides if it qualifies?
  4. Where and how do I request a State fair hearing, and by what date?
  5. Will Zepbound continue while the appeal is pending?
Sources for the facts on this sheet
  1. Legal Information Institute, Cornell Law School (U.S. Code text). 42 U.S. Code § 1396r-8 - Payment for covered outpatient drugs. Accessed 2026-10-18. https://www.law.cornell.edu/uscode/text/42/1396r-8
  2. Electronic Code of Federal Regulations (eCFR). 42 CFR 438.402 -- General requirements (grievance and appeal system). Accessed 2026-10-18. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-C/part-438/subpart-F/section-438.402
  3. Electronic Code of Federal Regulations (eCFR). 42 CFR 438.408 -- Resolution and notification: Grievances and appeals. Accessed 2026-10-18. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-C/part-438/subpart-F/section-438.408
  4. Electronic Code of Federal Regulations (eCFR). 42 CFR 431.244 -- Hearing decisions. Accessed 2026-10-18. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-C/part-431/subpart-E/subject-group-ECFR8f26a68cc25862f/section-431.244
  5. Missouri Department of Social Services, MO HealthNet Division. GLP-1 Receptor Agonists for All Indications: Prior Authorization (form 2575-053, April 2026). Accessed 2026-10-18. https://dss.mo.gov/sites/mydss/files/media/pdf/2026/07/2575-053-GLP-1-Receptor-Agonists-PA-Form-Tahoma.pdf
  6. California Department of Health Care Services, Medi-Cal Rx. GLP-1 Coverage Considerations (December 12, 2025; last updated April 6, 2026). Accessed 2026-10-18. https://medi-calrx.dhcs.ca.gov/cms/medicalrx/static-assets/documents/provider/2025/12_A_GLP-1_Coverage_Considerations.pdf

This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.